IMC Chicago’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.2M Sell
237,400
-403,300
-63% -$35.9M 0.01% 855
2025
Q4
$50.6M Buy
640,700
+447,600
+232% +$35.1M 0.02% 493
2025
Q3
$15.4M Buy
193,100
+33,900
+21% +$2.89M 0.01% 906
2025
Q2
$14.5M Sell
159,200
-34,600
-18% -$3.16M 0.01% 839
2025
Q1
$18.2M Sell
193,800
-12,500
-6% -$1.12M 0.01% 621
2024
Q4
$18.8M Sell
206,300
-111,500
-35% -$10.6M 0.01% 629
2024
Q3
$33M Buy
317,800
+3,800
+1% +$387K 0.02% 403
2024
Q2
$30.5M Buy
314,000
+190,700
+155% +$17.6M 0.02% 410
2024
Q1
$11.1M Buy
123,300
+34,600
+39% +$2.93M 0.01% 667
2023
Q4
$7.07M Buy
88,700
+53,300
+151% +$4.01M ﹤0.01% 763
2023
Q3
$2.52M Buy
+35,400
New +$2.65M ﹤0.01% 916

Other funds holding CL

IMC Chicago's CL Position: Q1 2026 in Review

IMC Chicago sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 39,978 shares — an estimated $3.56M sold.

IMC Chicago first reported a position in CL in Q3 2023 and held it in 7 quarters. The position peaked at $9.18M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • IMC Chicago reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 39,978 Colgate-Palmolive shares in Q1 2026, an estimated $3.56M.
  • IMC Chicago first reported a position in Colgate-Palmolive in Q3 2023 and held it in 7 quarters.
  • IMC Chicago's Colgate-Palmolive position peaked at $9.18M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.